| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/07/2005 | CA2550843A1 Novel phenylalanine derivatives |
| 07/07/2005 | CA2550655A1 Nicotinic acetylcholine receptor ligands |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | CA2549184A1 6-(aminocarbonyl-phenyl) triazolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 07/07/2005 | CA2547159A1 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds |
| 07/06/2005 | EP1550656A1 4-5-diamino-n,n-dihydro-pyrazol-3-one derivatives for use in composition for dyeing keratin fibres |
| 07/06/2005 | EP1549652A1 Fused azole-pyrimidine derivatives |
| 07/06/2005 | EP1549651A1 Kinase inhibitors |
| 07/06/2005 | EP1549641A1 Antimicrobial 3.1.0 bicyclic oxazolidinone derivatives |
| 07/06/2005 | EP1549637A1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 07/06/2005 | EP1549635A1 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases |
| 07/06/2005 | EP1549614A2 Vasculostatic agents and methods of use thereof |
| 07/06/2005 | EP1549319A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 07/06/2005 | EP1549315A2 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors |
| 07/06/2005 | EP1549313A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 07/06/2005 | EP1044001B1 Integrin receptor antagonists |
| 07/06/2005 | CN1635893A Use of a vitamin combination for the treatment of primary headaches |
| 07/06/2005 | CN1635882A Methods for treating hearing loss |
| 07/06/2005 | CN1635877A Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/06/2005 | CN1635871A Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 07/06/2005 | CN1634927A Spirofluorene materials containing non-benzene aromatic ring and synthesis and use thereof |
| 07/06/2005 | CN1634920A Method for extracting chlorophyl from silkworm faeces by microwave pretreatment and preparing chlorophyllin copper and sodium salts |
| 07/06/2005 | CN1209363C Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same |
| 07/05/2005 | US6914276 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device |
| 07/05/2005 | US6914066 1,2-annelated quinoline derivatives |
| 07/05/2005 | US6914065 Imidazo[1,2-C]pyrimidine derivatives as ligands for gaba receptors |
| 07/05/2005 | US6914063 Imidazo-pyrazine derivatives as ligands for GABA receptors |
| 07/05/2005 | US6914062 Pyrazinone derivatives |
| 07/05/2005 | US6914060 Treatment of anxiety, convulsions and cognitive disorders |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 07/05/2005 | CA2072541C Heterocyclic compounds, their production and use |
| 06/30/2005 | WO2005058913A1 Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents |
| 06/30/2005 | WO2005058908A1 SUBSTITUTED 8’-PYRI(MI)DINYL-DIHYDROSPIRO-[CYCLOALKYLAMINE]-PYRIMIDO[1,2-a]PYRIMIDIN-6-ONE DERIVATIVES |
| 06/30/2005 | WO2005058907A1 6-(2-halophenyl)-triazolopyrimidines, method for their production and their use for combating pathogenic fungi, in addition to agents containing said substances |
| 06/30/2005 | WO2005058906A1 6-(2-chloro-4-alkoxy-phenyl)-triazolopyrimidine, method for the production thereof and its utilization for controlling fungi and the agents contained therein |
| 06/30/2005 | WO2005058905A1 6-(2-fluoride-4-alcoxyphenyl)-triazolopyrimidine, method for the production and use thereof against harmful fungus and agents containing said product |
| 06/30/2005 | WO2005058904A1 6-pentafluorophenyl-triazolopyrimidines, method for their production and their use for combating pathogenic fungi, in addition to agents containing said substances |
| 06/30/2005 | WO2005058903A1 6-(2,4,6-trihalophenyl)-triazolopyrimidines, method for their production and their use for combating pathogenic fungi, in addition to agents containing said substances |
| 06/30/2005 | WO2005058902A1 6-(2,3,6-trifluorophenyl)-triazolopyrimidines for combating pathogenic fungi |
| 06/30/2005 | WO2005058901A1 Novel 2-(piperazin-1-yl)- and 2-([1,4]diazepan-1-yl)- imidazo[4,5-d]pyridazin-4-one, production and use thereof as medicament for the treatment of diabetes mellitus |
| 06/30/2005 | WO2005058900A1 6-(2,4,6-trifluorophenyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 06/30/2005 | WO2005058899A1 Pyrazolopyrimidinethione Derivatives, Salts and Solvates thereof, Preparation Methods and Use thereof |
| 06/30/2005 | WO2005058890A2 Hydronopol derivatives as agonists on human orl1 receptors |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058835A2 Methods of preparing aripiprazole crystalline forms |
| 06/30/2005 | WO2005058814A2 Biocidal siloxane coating material containing n-halogenated amine and amide functional groups |
| 06/30/2005 | WO2005058245A2 Synthetic process |
| 06/30/2005 | WO2005040170A3 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| 06/30/2005 | WO2005035533A8 Modulators of serotonin receptors |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2004100960A8 Anti-inflammatory phosphonate compounds |
| 06/30/2005 | WO2004096236A3 Immunomodulator phosphonate conjugates |
| 06/30/2005 | WO2004084809A3 Neuroprotective macrocylic compounds and methods for their use |
| 06/30/2005 | WO2004075847A3 METHODS AND COMPOUNDS FOR THE TREATMENT OF Aß ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS |
| 06/30/2005 | WO2004041826A8 Imidazopyrazinones and imidazotriazinones derivates as gaba-a receptor anxiolytic |
| 06/30/2005 | WO2004026310A8 Novel imidazopyrazines as cyclin dependent kinase inhibitors |
| 06/30/2005 | WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 06/30/2005 | US20050143442 For inhibition of angiogenesis; as antitumor agents; for enhancing the function and/or survival of cells of neuronal lineage, either singularly or in combination with neurotrophic factor(s) and/or indolocarbazoles; for enhancing trophic factor-induced activity; inhibition of kinase activity |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143399 Novel compounds |
| 06/30/2005 | US20050143398 mitogen-activated protein (MAP), p38 kinase ( alpha and beta)-associated conditions; antiinflammatory and antidiabetic agent; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, asthma |
| 06/30/2005 | US20050143397 Processes for preparation of ziprasidone |
| 06/30/2005 | US20050143388 Nitric oxide donors for treatment of disease and injury |
| 06/30/2005 | US20050143381 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 06/30/2005 | US20050143380 Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
| 06/30/2005 | US20050143377 Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/30/2005 | US20050143370 Therapeutic compounds |
| 06/30/2005 | US20050143367 Making type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors, e.g. erectile dysfunction drug 5-(5-Acetyl-2-butoxy-3-pyridinyl)-3-ethyl-2-(1-ethyl-3-azetidinyl)-2,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one; use of hydroxide trapping agent; higher yield |
| 06/30/2005 | CA2550726A1 Methods of preparing aripiprazole crystalline forms |
| 06/30/2005 | CA2550168A1 Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-.alpha.]pyrimidin-6-one derivatives |
| 06/30/2005 | CA2550012A1 Urea derivative, process for producing the same and use |
| 06/30/2005 | CA2549869A1 Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549169A1 6-(2-halophenyl)-triazolopyrimidines, method for their production and their use for combating pathogenic fungi, in addition to agents containing said substances |
| 06/30/2005 | CA2548351A1 6-(2-chloro-4-alkoxy-phenyl)-triazolopyrimidine, method for the production thereof and its utilization for controlling fungi and the agents contained therein |
| 06/30/2005 | CA2547633A1 Hydronopol derivatives as agonists on human orl1 receptors |
| 06/30/2005 | CA2543074A1 Novel 2-(piperazin-1-yl)- and 2-([1,4]diazepan-1-yl)- imidazo[4,5-d]pyridazin-4-one, production and use thereof as medicament for the treatment of diabetes mellitus |
| 06/29/2005 | EP1546391A2 Energy transfer dyes, terminators and use thereof |
| 06/29/2005 | EP1546284A1 Reactive dendrimers |
| 06/29/2005 | EP1546150A1 Biologically active compounds |
| 06/29/2005 | EP1546125A2 Fluorescent labeling reagents with multiple donors and acceptors |
| 06/29/2005 | EP1546115A2 Substituted pyrimidines |
| 06/29/2005 | EP1546112A2 Imidazolopyridines and methods of making and using the same |
| 06/29/2005 | EP1545545A2 COMPOUNDS WITH THE BICYCLO 4.2.1 NONANE SYSTEM FOR THE TREATMENT OF i FLAVIVIRIDAE /i INFECTIONS |
| 06/29/2005 | EP1545533A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/29/2005 | EP1463729A4 A process for producing phenserine and its analog |
| 06/29/2005 | EP1373272B1 Tert. alkylphenoxy substituted polycyclic compounds |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | EP1152762B8 Use of desoxypeganine in the treatment of alzheimer's dementia |
| 06/29/2005 | CN1633437A Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 06/29/2005 | CN1633436A Pyrrolopyrimidine derivatives |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633298A Novel use of 2-phenyl-substituted imidazotriazinones |
| 06/29/2005 | CN1631890A Tetraphenyl porphyrin derivative and its application in organic electroluminescent device |
| 06/29/2005 | CN1208366C Light-emitting dendrimers and devices |
| 06/29/2005 | CN1208337C Preparation of Xibo ketone |
| 06/29/2005 | CN1208336C Tert-butyl-(7-methyl-imidazo [1, 2-a] pyridine-3-yl)-amine derivatives |
| 06/29/2005 | CN1208318C Cycloamine CCR5 receptor antagonists |
| 06/28/2005 | US6911543 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |